News & Events

Biotechgate Digital Partnering

Meet our team at the Biotechgate Digital Partnering event, designed to support global Business Development in Biotech, Medtech & Pharma.

4 days of digital partnering devoted to new business opportunities for Software development & Consultation on Regulatory affairs.

Biotech & Pharma

Virtual Partnering Conference 2020

Join us at the Biotech & Pharma Partnering event to discuss new business opportunities for Software development & Consultation on Regulatory affairs.
Co-organised by the EU-Japan Centre for Industrial Cooperation & the Osaka Prefectural Government, the event is supported by EEN & various Bioclusters from Japan and Europe.

MedtecLIVE 2020

MedtecLIVE 2020 & MedTech Summit GO VIRTUAL!

Use the MedTech virtual platform to contact and network with Repado!

Explore our Software Development & Consultation Services for your new project!

DMEA Think Medical!
Act Digital!

DMEA goes digital! Join us for a b2b virtual meeting to discuss how our software development services and regulatory consultation can help you with your next project!

Find more about DMEA 2020

LTM Platform

Free Access
for LTM Platform

Repado contributes in the Covidfight and offers FREE access to its Medical Device Management Platform for ALL Hospital & Research Labs!

Use LTM, to access and support your medical devices, to enable their non-stop performance in the field!

LTM interconnects Manufacturers, Service Professionals and End Users of medical devices under one single application that provides holistic support.

  • Connect, Monitor & Manage multiple devices in the field
  • Create your own Network of Customers & Suppliers
  • Provide & Receive premium Support Serviceson device failure
  • Access Real-time data: runtime info, protocols & reagents, logs, errors

Contact us at to set up LTM in your Lab!



Our warmest congratulations to our long term partners at GENOMICA SAU for achieving CE-IVD approval for their diagnostic kits against the COVID-19.

Repado, as GENOMICA’s Software Partner for its CAR® and AUTOCLART® Plus Solutions that use the CLART® technology, is proud and will continue to actively support GENOMICA worldwide in the COVID-19 fight.

CLART® technology used by GENOMICA has the capacity to simultaneously analyze 96 patient samples in less than 5 hours, while the GENOMICA diagnostic kits are highly sensitive and specific in detecting COVID-19, even before the patient shows symptoms!